New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New findings shed light on selective therapeutics for IDH1-mutated glioma

New findings shed light on selective therapeutics for IDH1-mutated glioma

byChinese Academy of SciencesGlutathione synthesis is controlled by Nrf2 transcription factor, and can be disrupted by triptolide. Credit: DICPFindings of a new study led by Prof. Xu Guowang fro
World medicine December 09,2023
New findings shed light on selective therapeutics for IDH1-mutated glioma

New findings shed light on selective therapeutics for IDH1-mutated glioma

byChinese Academy of SciencesGlutathione synthesis is controlled by Nrf2 transcription factor, and can be disrupted by triptolide. Credit: DICPFindings of a new study led by Prof. Xu Guowang fro
World medicine December 09,2023
RNA drugs one step closer to be being used in cancer treatment

RNA drugs one step closer to be being used in cancer treatment

byLund UniversityMembrane damage caused by chloroquine in tumour spheroids.Cervical cancer cells cultivated as smalltumours in test tubes, so-called tumour spheroids. The spheroid on
World medicine December 09,2023
RNA drugs one step closer to be being used in cancer treatment

RNA drugs one step closer to be being used in cancer treatment

byLund UniversityMembrane damage caused by chloroquine in tumour spheroids.Cervical cancer cells cultivated as smalltumours in test tubes, so-called tumour spheroids. The spheroid on
World medicine December 09,2023
Pancreatic cancer blocked by disrupting cellular pH balance

Pancreatic cancer blocked by disrupting cellular pH balance

bySanford Burnham Prebys Medical Discovery InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainScientists at Sanford Burnham Preby
World medicine December 09,2023
Pancreatic cancer blocked by disrupting cellular pH balance

Pancreatic cancer blocked by disrupting cellular pH balance

bySanford Burnham Prebys Medical Discovery InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainScientists at Sanford Burnham Preby
World medicine December 09,2023
Meta-analysis explores the mechanism that connects cancer and diabetes

Meta-analysis explores the mechanism that connects cancer and diabetes

byUniversity of CopenhagenCredit: Pixabay/CC0 Public DomainBack in the 1920s, researchers discovered that cancer patients had sweet-smelling urine. First, the doctors were puzzled, but they soon
World medicine December 09,2023
Meta-analysis explores the mechanism that connects cancer and diabetes

Meta-analysis explores the mechanism that connects cancer and diabetes

byUniversity of CopenhagenCredit: Pixabay/CC0 Public DomainBack in the 1920s, researchers discovered that cancer patients had sweet-smelling urine. First, the doctors were puzzled, but they soon
World medicine December 09,2023
Those living in rural areas, uninsured or on Medicaid less likely to receive recommended lung cancer treatment

Those living in rural areas, uninsured or on Medicaid less likely to receive recommended lung cancer treatment

byUniversity of Southern CaliforniaElizabeth A. David, MD, MAS, a cardiothoracic surgeon with Keck Medicine of USC. Credit: Ricardo Carrasco IIILung cancer is the leading cause of cancer-associa
World medicine December 09,2023
Those living in rural areas, uninsured or on Medicaid less likely to receive recommended lung cancer treatment

Those living in rural areas, uninsured or on Medicaid less likely to receive recommended lung cancer treatment

byUniversity of Southern CaliforniaElizabeth A. David, MD, MAS, a cardiothoracic surgeon with Keck Medicine of USC. Credit: Ricardo Carrasco IIILung cancer is the leading cause of cancer-associa
World medicine December 09,2023
Researchers find common therapeutic vulnerability for a genetically diverse and deadly leukaemia

Researchers find common therapeutic vulnerability for a genetically diverse and deadly leukaemia

byDuke-NUS Medical SchoolCredit: CC0 Public DomainScientists and clinicians from Duke-NUS Medical School, the Agency for Science, Technology and Research's (A*STAR's) Genome Institute of
World medicine December 09,2023
Researchers find common therapeutic vulnerability for a genetically diverse and deadly leukaemia

Researchers find common therapeutic vulnerability for a genetically diverse and deadly leukaemia

byDuke-NUS Medical SchoolCredit: CC0 Public DomainScientists and clinicians from Duke-NUS Medical School, the Agency for Science, Technology and Research's (A*STAR's) Genome Institute of
World medicine December 09,2023
Intense form of radiation slows disease progression in some men with prostate cancer

Intense form of radiation slows disease progression in some men with prostate cancer

byJohns Hopkins University School of MedicineProstate cancer. Credit: Phuoc Tran, M.D., Ph.D.Highly focused, intense doses of radiation called stereotactic ablative radiation (SABR) may slow pro
World medicine December 09,2023
Intense form of radiation slows disease progression in some men with prostate cancer

Intense form of radiation slows disease progression in some men with prostate cancer

byJohns Hopkins University School of MedicineProstate cancer. Credit: Phuoc Tran, M.D., Ph.D.Highly focused, intense doses of radiation called stereotactic ablative radiation (SABR) may slow pro
World medicine December 09,2023
3-D genetic structure in blood cancer important beyond DNA code changes

3-D genetic structure in blood cancer important beyond DNA code changes

byNYU Langone HealthCredit: CC0 Public DomainChildren with aggressive blood cancers have differences—not just in the DNA code of their blood cells—but also in the heavily twisted protein superst
World medicine December 09,2023
3-D genetic structure in blood cancer important beyond DNA code changes

3-D genetic structure in blood cancer important beyond DNA code changes

byNYU Langone HealthCredit: CC0 Public DomainChildren with aggressive blood cancers have differences—not just in the DNA code of their blood cells—but also in the heavily twisted protein superst
World medicine December 09,2023
Disasters can affect cervical cancer screening for years

Disasters can affect cervical cancer screening for years

byTohoku UniversityCervical Cancer Screening Bus. Credit: Miki et al.Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan
World medicine December 09,2023
Disasters can affect cervical cancer screening for years

Disasters can affect cervical cancer screening for years

byTohoku UniversityCervical Cancer Screening Bus. Credit: Miki et al.Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan
World medicine December 09,2023
New drug combination passes safety test in pancreatic cancer

New drug combination passes safety test in pancreatic cancer

byMary Ann Liebert, IncAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study has shown a novel peptide antagonist, given in combi
World medicine December 09,2023
New drug combination passes safety test in pancreatic cancer

New drug combination passes safety test in pancreatic cancer

byMary Ann Liebert, IncAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study has shown a novel peptide antagonist, given in combi
World medicine December 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com